Fresenius SE KGaA (LTS:0OO9) Receipts from Customers

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0OO9 Fresenius SE & Co KGaA LTS:0OO9
69 GF Score
Price €45.22
GF Value €39.46
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA Receipts from Customers?

Receipts from Customers only applicable to companies reporting Cash Flow from Operations in direct method.

LTS:0OO9
69GF Score
Fresenius SE & Co KGaA LTS:0OO9
Receipts from Customers is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fresenius SE KGaA (LTS:0OO9) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of €45.22 is trading 14.6% above its estimated GF Value™ of €39.46. GuruFocus considers Fresenius SE KGaA to be Modestly Overvalued.

Key valuation signals for LTS:0OO9:

  • Receipts from Customers:
  • GF Value™: €39.46 vs. price of €45.22 (14.6% above fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the LTS:0OO9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius SE & Co KGaA is a German healthcare group operating through several business segments. Fresenius Kabi develops and manufactures generic intravenous drugs, clinical nutrition products, infusion and transfusion therapies, and related medical devices such as infusion pumps, serving hospitals and outpatient care providers worldwide. Fresenius Helios is Europe's largest private hospital operator, running acute care and post-acute facilities in Germany and Spain, including the Quironsalud network. Fresenius Vamed provides project management, engineering, and technical and management services for healthcare facilities. The company also holds a majority stake in Fresenius Medical Care, the dialysis products and services provider, which it has been gradually deconsolidating. Fresenius generates revenue from product sales, hospital patient care, and service contracts, with operations spanning Europe, North America, Latin America, Africa, and Asia-Pacific.
69GF Score

Get the complete analysis for LTS:0OO9

Receipts from Customers is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€45.22
Price
€39.46
GF Value